This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Keio University. Active years: 2017-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokyo, JP (2017)
- Kamakura, JP (2022)
Company Filing History:
Years Active: 2017-2022
Title: Masato Yasui: Innovator in Monoclonal Antibodies and Light Generation
Introduction
Masato Yasui is a prominent inventor based in Kamakura, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies and compounds for generating second harmonic light. With a total of 2 patents, Yasui's work has the potential to impact various scientific and medical applications.
Latest Patents
Yasui's latest patents include an anti AQP3 monoclonal antibody specifically binding to the extracellular domain of aquaporin 3 (AQP3). This invention aims to provide an antibody that recognizes AQP3, a water channel protein, and can inhibit its function, thereby controlling the permeation of low molecular weight molecules. His second patent involves a compound for generating second harmonic light, which suppresses the generation of two-photon fluorescence signals. This compound, an azobenzene derivative, is designed for use in cell examination methods.
Career Highlights
Masato Yasui is affiliated with Keio University, where he conducts research and develops innovative solutions in biotechnology. His work has garnered attention for its potential applications in medical diagnostics and therapeutic interventions.
Collaborations
Yasui collaborates with notable colleagues, including Mariko Chikuma and Atsuya Momotake. Their combined expertise enhances the research and development efforts in their respective fields.
Conclusion
Masato Yasui's contributions to the fields of monoclonal antibodies and light generation exemplify the innovative spirit of modern science. His patents reflect a commitment to advancing technology for practical applications in healthcare and research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
